{"id":"https://openalex.org/W3035540697","doi":"https://doi.org/10.1021/acsinfecdis.0c00044","title":"The Antibacterial Research and Development Pipeline Needs Urgent Solutions","display_name":"The Antibacterial Research and Development Pipeline Needs Urgent Solutions","alternate_titles":[],"publication_year":2020,"publication_date":"2020-06-12","ids":{"openalex":"https://openalex.org/W3035540697","doi":"https://doi.org/10.1021/acsinfecdis.0c00044","mag":"3035540697"},"language":"en","primary_location":{"id":"doi:10.1021/acsinfecdis.0c00044","doi":"https://doi.org/10.1021/acsinfecdis.0c00044","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acsinfecdis.0c00044","pdf_url":null,"source":{"id":"https://openalex.org/S2764646616","display_name":"ACS Infectious Diseases","issn_l":"2373-8227","issn":["2373-8227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3035540697"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Peter Beyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105654","display_name":"World Health Organization","ror":"https://ror.org/01f80g185","country_code":"CH","type":"government","lineage":["https://openalex.org/I4210105654"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Peter Beyer","raw_affiliation_strings":["AMR Division, World Health Organization, Geneva 1202, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AMR Division, World Health Organization, Geneva 1202, Switzerland","institution_ids":["https://openalex.org/I4210105654"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015749292","display_name":"Sarah Paulin","orcid":"https://orcid.org/0000-0002-9341-1196","observed_orcids":["https://orcid.org/0000-0002-9341-1196"]},"institutions":[{"id":"https://openalex.org/I4210105654","display_name":"World Health Organization","ror":"https://ror.org/01f80g185","country_code":"CH","type":"government","lineage":["https://openalex.org/I4210105654"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sarah Paulin","raw_affiliation_strings":["AMR Division, World Health Organization, Geneva 1202, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-9341-1196","affiliations":[{"raw_affiliation_string":"AMR Division, World Health Organization, Geneva 1202, Switzerland","institution_ids":["https://openalex.org/I4210105654"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210105654"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":106,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"6","first_page":"1289","last_page":"1291"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.41819998621940613,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.41819998621940613,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.37549999356269836,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.17159999907016754,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibiotic-pipeline","display_name":"antibiotic pipeline","score":0.6190000176429749},{"id":"https://openalex.org/keywords/antibacterial-drug-development","display_name":"antibacterial drug development","score":0.8190000057220459},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.8019999861717224},{"id":"https://openalex.org/keywords/gram-negative-infections","display_name":"gram-negative bacterial infection","score":0.890999972820282},{"id":"https://openalex.org/keywords/who-priority-pathogens","display_name":"WHO priority pathogens","score":0.9779999852180481},{"id":"https://openalex.org/keywords/small-and-medium-sized-enterprises","display_name":"small and medium-sized enterprises","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C43521106","wikidata":"https://www.wikidata.org/wiki/Q2165493","display_name":"Pipeline (software)","level":2,"score":0.8484973907470703},{"id":"https://openalex.org/C191172861","wikidata":"https://www.wikidata.org/wiki/Q7899321","display_name":"Upstream (networking)","level":2,"score":0.5334814786911011},{"id":"https://openalex.org/C27548731","wikidata":"https://www.wikidata.org/wiki/Q88272","display_name":"Investment (military)","level":3,"score":0.5122432112693787},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4984416961669922},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.43993932008743286},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.36936506628990173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3646896481513977},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.34653139114379883},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.289821982383728},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1716979742050171},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.16051584482192993},{"id":"https://openalex.org/C94625758","wikidata":"https://www.wikidata.org/wiki/Q7163","display_name":"Politics","level":2,"score":0.0},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/acsinfecdis.0c00044","doi":"https://doi.org/10.1021/acsinfecdis.0c00044","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acsinfecdis.0c00044","pdf_url":null,"source":{"id":"https://openalex.org/S2764646616","display_name":"ACS Infectious Diseases","issn_l":"2373-8227","issn":["2373-8227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Infectious Diseases","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307856","display_name":"World Health Organization","ror":"https://ror.org/01f80g185"},{"id":"https://openalex.org/F4320328261","display_name":"Drugs for Neglected Diseases initiative","ror":"https://ror.org/022mz6y25"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2883272117","https://openalex.org/W2991330881"],"related_works":["https://openalex.org/W2726755447","https://openalex.org/W3045788169","https://openalex.org/W2766045239","https://openalex.org/W2991330881","https://openalex.org/W4379966703","https://openalex.org/W898681051","https://openalex.org/W4408901860","https://openalex.org/W2596515345","https://openalex.org/W2005015013","https://openalex.org/W7165863205"],"abstract_inverted_index":{"Despite":[0],"ongoing":[1],"efforts":[2],"to":[3,21],"stimulate":[4],"investment":[5],"and":[6,41,54,142,147,164],"research":[7],"into":[8],"the":[9,14,34,39,47,67,72,85,91,95,116,121,139,151,160],"development":[10,105],"of":[11,58,76,84,106,118,150],"new":[12,30,171],"antibiotics,":[13],"clinical":[15,42,49,68],"pipeline":[16,44,50,69,97,125],"remains":[17],"insufficient,":[18],"in":[19,66,103,120,138],"particular":[20],"treat":[22],"critical":[23],"resistant":[24],"Gram-negative":[25],"bacterial":[26],"infections.":[27],"The":[28,124],"two":[29],"reports":[31],"released":[32],"by":[33,56,90],"World":[35],"Health":[36],"Organization":[37],"on":[38,130],"preclinical":[40,96,104,122],"antibacterial":[43,101],"show":[45],"that":[46,70,159],"current":[48],"is":[51,126,136,154,157],"very":[52],"dry":[53],"dominated":[55],"derivatives":[57],"existing":[59],"classes.":[60],"There":[61],"are":[62,111,168],"only":[63,78],"32":[64],"antibacterials":[65],"target":[71],"WHO":[73],"priority":[74],"pathogens,":[75],"which":[77,107,114,135],"6":[79],"fulfill":[80],"at":[81],"least":[82],"1":[83],"innovation":[86,119],"criteria":[87],"as":[88],"defined":[89],"WHO.":[92],"Further":[93],"upstream,":[94],"review":[98],"identified":[99],"252":[100],"agents":[102],"over":[108],"one":[109],"third":[110],"nontraditioanl":[112],"products":[113],"highlights":[115],"degree":[117],"pipeline.":[123],"also":[127],"heavily":[128],"reliant":[129],"small-":[131],"or":[132],"medium-sized":[133],"enterprises,":[134],"unsustainable":[137],"long":[140],"run,":[141],"more":[143,145],"investment,":[144],"players,":[146],"a":[148],"rethinking":[149],"market":[152],"dynamics":[153],"needed.":[155],"It":[156],"encouraging":[158],"pharmaceutical":[161],"industry,":[162],"governments,":[163],"other":[165],"concerned":[166],"stakeholders":[167],"currently":[169],"discussing":[170],"ideas.":[172]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3035540697","counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":28},{"year":2023,"cited_by_count":18},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-06-19T00:00:00"}
